Rohit Duggal

Title: Rohit Duggal: Innovator in Cellular Therapies

Introduction

Rohit Duggal is a prominent inventor based in San Diego, California. He has made significant contributions to the field of cellular therapies, particularly in the development of innovative methods for culturing immune cells. With a total of four patents to his name, Duggal's work is paving the way for advancements in medical treatments.

Latest Patents

Duggal's latest patents include groundbreaking methods for preparing mononuclear cell-derived NK cells. These NK cells are derived from whole blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without the need for a feeder layer. The methods utilize an enrichment process involving anti-CD16 agonist antibodies, anti-CD3 antibodies, and N-803. Additionally, these processes are designed to be adaptable into a fully automated production process, referred to as GMP in a box. Another notable patent involves generating CIK NKT cells from cord blood, which includes customized media compositions for culturing these specialized immune cells.

Career Highlights

Throughout his career, Duggal has worked with leading companies in the biotechnology sector, including ImmunityBio, Inc. and NantKwest Inc. His experience in these organizations has allowed him to refine his expertise in cellular therapies and contribute to innovative research.

Collaborations

Duggal has collaborated with notable professionals in his field, including Ranjeet Sinha and Wenzhao Li. These partnerships have further enhanced his research and development efforts in cellular therapies.

Conclusion

Rohit Duggal is a distinguished inventor whose work in cellular therapies is making a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.